Want to see HK:1907 full AI Analyst Report?
Top Page
China Risun Group Ltd.
(1907)
Select Model
Select Model
Rating:41Neutral
Price Target:
HK$1.50
▼(-33.04% Downside)
Action:Upgraded
Date:09/18/26
The score is held down primarily by weakened financial performance (near-breakeven profitability, declining revenue, and higher leverage). Technicals also remain bearish with the stock trading below major moving averages and negative momentum indicators. Valuation offers limited support given a high P/E and modest dividend yield.
Positive Factors
Improved Operating Cash Flow
The sharp improvement in operating cash flow indicates that the business generated substantially more cash from operations in 2025. Positive operating cash flow provides funding for working capital, debt service, and investment, although continued consistency will be important for making this strength durable.
Negative Factors
Revenue Contraction
The decline in revenue signals weaker recent demand, pricing, volumes, or a combination of these factors across the company’s industrial markets. Persistent top-line contraction would reduce operating leverage and make it harder for China Risun to rebuild profitability or absorb fixed production costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Operating Cash Flow
The sharp improvement in operating cash flow indicates that the business generated substantially more cash from operations in 2025. Positive operating cash flow provides funding for working capital, debt service, and investment, although continued consistency will be important for making this strength durable.
Read all positive factors
China Risun Group Ltd. (1907) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$6.86B
Dividend Yield1.23%
Average Volume (3M)4.87M
Price to Earnings (P/E)24.0
Beta (1Y)0.39
Revenue Growth-1.88%
EPS GrowthN/A
CountryHK
Employees7,285
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)0.05
Shares Outstanding4,454,186,000
10 Day Avg. Volume3,052,814
30 Day Avg. Volume4,872,075
Financial Highlights & Ratios
PEG Ratio0.84
Price to Book (P/B)0.70
Price to Sales (P/S)0.22
P/FCF Ratio14.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$2.68Price Target Upside19.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.24
Revenue Forecast (FY)HK$48.71B
China Risun Group Ltd. Business Overview & Revenue Model
Company Description
China Risun Group Limited, founded in 1995 and headquartered in Beijing, People's Republic of China, is a diversified enterprise focused on the manufacturing, sale, and distribution of coke, coking chemicals, and refined chemicals throughout the P...
How the Company Makes Money
China Risun Group Ltd. primarily makes money by manufacturing and selling (1) metallurgical coke and (2) coking-chemicals derived from the coking process. Revenue is generated through sales contracts and spot sales to industrial customers, with pr...
China Risun Group Ltd. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
38
Negative
Cash Flow
41
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.59B | 39.29B | 47.54B | 46.07B | 43.14B | 39.37B |
| Gross Profit | 3.69B | 3.06B | 3.49B | 3.32B | 4.28B | 5.53B |
| EBITDA | 3.46B | 3.14B | 3.61B | 4.37B | 4.63B | 5.45B |
| Net Income | 233.34M | 58.01M | 20.13M | 860.81M | 1.86B | 2.61B |
Balance Sheet | ||||||
| Total Assets | 74.53B | 61.89B | 59.84B | 53.84B | 46.10B | 36.80B |
| Cash, Cash Equivalents and Short-Term Investments | 10.09B | 5.08B | 2.26B | 1.25B | 1.40B | 2.37B |
| Total Debt | 45.05B | 37.20B | 30.38B | 26.31B | 20.70B | 16.70B |
| Total Liabilities | 58.53B | 46.80B | 43.96B | 39.36B | 33.51B | 25.69B |
| Stockholders Equity | 12.16B | 12.50B | 12.76B | 12.90B | 12.11B | 10.98B |
Cash Flow | ||||||
| Free Cash Flow | -397.78M | 622.44M | -1.24B | 134.87M | -1.22B | 534.69M |
| Operating Cash Flow | 2.80B | 3.46B | 1.44B | 2.20B | 3.16B | 4.21B |
| Investing Cash Flow | -1.02B | -3.41B | -3.64B | -1.71B | -9.18B | -5.13B |
| Financing Cash Flow | 1.25B | -570.24M | 3.05B | -455.15M | 4.93B | 2.02B |
China Risun Group Ltd. Technical Analysis
Negative
2.24
Price Trends
1.75
Negative
1.87
Negative
2.33
Negative
Market Momentum
-0.05
Negative
38.21
Neutral
35.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1907, the sentiment is Negative. The current price of 2.24 is above the 20-day moving average (MA) of 1.62, above the 50-day MA of 1.75, and below the 200-day MA of 2.33, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 38.21 is Neutral, neither overbought nor oversold. The STOCH value of 35.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1907.
China Risun Group Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$3.56B | 6.17 | 8.77% | 8.10% | 2.52% | 2.16% | |
65 Neutral | HK$16.00B | 7.45 | 12.67% | 3.11% | 7.79% | 48.48% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$4.12B | 4.58 | 13.63% | 4.26% | 0.90% | 16.54% | |
50 Neutral | HK$10.91B | -15.78 | -18.41% | 0.83% | 165.47% | -398.61% | |
42 Neutral | HK$217.87M | -0.24 | 214.56% | ― | 1.56% | -21.85% | |
41 Neutral | HK$6.86B | 24.02 | 1.89% | 1.23% | -1.88% | ― |
* Basic Materials Sector Average
HK:1907
China Risun Group Ltd.
1.54
-0.79
-33.85%
HK:0827
Ko Yo Chemical (Group) Limited
0.03
<0.01
14.81%
HK:0189
Dongyue Group Limited
9.66
-0.13
-1.36%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
3.52
1.20
51.51%
HK:6616
Global New Material International Holdings Limited
8.74
2.58
41.88%
HK:0746
Lee & Man Chemical Co. Ltd.
4.32
-0.15
-3.33%
China Risun Group Ltd. Corporate Events
China Risun’s Binhai Energy Posts Surging Revenue but Deepening Cash Outflows
Oct 29, 2026
China Risun Group Limited has highlighted the performance of its Shenzhen-listed subsidiary Tianjin Binhai Energy Development Co., Ltd., which operates in China’s energy-related industrial sector and contributes materially to the group̵...
China Risun Calls EGM to Approve Capital Injection and Service Agreements
Oct 29, 2026
China Risun Group Limited has called an extraordinary general meeting in Hong Kong on November 19, 2026, where shareholders will vote on several ordinary resolutions tied to key operating agreements. The meeting underscores the company’s rel...
China Risun Delays Shareholder Circular on Capital Injection and Revised Caps
Oct 23, 2026
China Risun Group Limited has announced a delay in sending a circular to shareholders that outlines details of a proposed capital injection and revisions to annual caps under project services and integrated procurement supplemental agreements. The...
China Risun shareholders back framework agreement and funding limits through 2028
Oct 22, 2026
China Risun Group Limited announced that shareholders approved an ordinary resolution at an extraordinary general meeting held in Hong Kong on October 22, 2026. The meeting, overseen by Tricor Investor Services Limited as scrutineer, recorded stro...
China Risun Calls 2026 EGM to Approve Framework Agreement and Balances
Sep 29, 2026
China Risun Group Limited has called an extraordinary general meeting for October 22, 2026, in Hong Kong to seek shareholder approval of a framework agreement and related transactional arrangements. The board will ask investors to endorse the agre...
China Risun Raises Caps on Connected Transactions With Controlling Shareholder’s Group
Sep 28, 2026
China Risun Group has announced revisions to the annual caps for its continuing connected transactions with Xuyang Holding under both its project services and integrated procurement framework agreements, covering the period from 2025 to 2027. The ...
China Risun to Boost Stake in Xiangfu New Energy with RMB507 Million Injection
Sep 23, 2026
China Risun Group Limited plans to inject RMB506.94 million in cash into its non-wholly-owned subsidiary Xiangfu New Energy, with RMB217.19 million to be added to registered capital and RMB289.75 million to capital reserves. Following the injectio...
China Risun Sets Up Related-Party Financing Framework for New Energy Projects
Sep 23, 2026
China Risun Group’s subsidiary Binhai Energy has entered into a framework agreement with three connected project companies and shareholder-controlled Xuyang Holding to provide loans and guarantees through the end of 2028. Xuyang Holding will...
China Risun Profit Soars on Higher Margins as New-Energy Materials Offset Coke Slowdown
Aug 28, 2026
China Risun Group Limited reported mixed operating volumes for the first half of 2026, with coke and refined chemicals output down 13.8% and 10.3% year-on-year, and high-purity hydrogen production falling 17.4%, while lithium battery anode materia...
China Risun Declares Interim Dividend for First Half of 2026
Aug 28, 2026
China Risun Group Limited has declared an interim ordinary cash dividend of RMB 0.0144 per share for the six months ended June 30, 2026, for the financial year ending December 31, 2026. The dividend will be paid in Hong Kong dollars at HKD 0.0167 ...
China Risun Approves RMB300 Million Connected Loans to New Energy Subsidiaries
Aug 25, 2026
China Risun Group has approved loan arrangements to support two connected new energy subsidiaries, Xiangfu New Energy and Xingtai New Energy, through its wholly-owned unit Risun Group. The loans, capped at RMB200 million for Xiangfu and RMB100 mil...
China Risun Board to Review Interim Results and Consider Dividend
Aug 18, 2026
China Risun Group Limited has scheduled a board meeting for August 28, 2026 to review and approve its interim results for the six months ended June 30, 2026. The board will also consider the declaration of an interim dividend, signaling potential ...
China Risun forecasts over 335% profit surge on chemical margins, Binhai Energy integration
Aug 10, 2026
China Risun Group expects net profit for the six months ended June 30, 2026 to rise by at least 335% from a year earlier, driven primarily by wider price spreads in its refined chemical products. Higher average selling prices for caprolactam, whil...
China Risun’s Binhai Energy Narrows Loss as Revenue Surges but Cash Outflows Deepen
Aug 9, 2026
China Risun Group disclosed interim financial data for its Shenzhen-listed subsidiary Tianjin Binhai Energy Development for the six months ended 30 June 2026. Binhai Energy reported a sharp 78.5% rise in operating revenue to RMB419.3 million, alo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.